COMP <GO>

AAPG vs PCRX // FORWARD P/E MULTIPLE

Ascentage Pharma Group International American Depository Shares (NASDAQ) VS. Pacira BioSciences Inc. (NASDAQ) • 15-METRIC TALLY: AAPG 0 — PCRX 2

■ METRIC PARITY

AAPG — Ascentage Pharma Group International American Depository Shares ROARABLE D+ • RQD 57/100

LAST: $14.88 (-0.70%) • MKT CAP: $1.39B

DES <GO> FA <GO> 10-K RED <GO>

forward-pe

—

PCRX — Pacira BioSciences Inc. ROARABLE D+ • RQD 54/100

LAST: $36.39 (0.00%) • MKT CAP: $1.45B

DES <GO> FA <GO> 10-K RED <GO>

forward-pe

—

15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AAPG VS. PCRX) EMERALD CELL = QUANTITATIVE EDGE

INSTITUTIONAL METRIC	AAPG	PCRX	SPREAD (A - B)	ADVANTAGE	DEDICATED URL
Gross Profit Margin	—	79.40%	—	TIE	/gross-margins <GO>
Return on Invested Capital (ROIC)	—	1.70%	—	TIE	/roic <GO>
EV/EBITDA & P/E Valuation	—	51.6x	—	TIE	/valuation <GO>
Free Cash Flow Yield	—	9.42%	—	TIE	/fcf-yield <GO>
Operating Margin	—	2.60%	—	TIE	/operating-margins <GO>
Net Profit Margin	—	1.00%	—	TIE	/net-margins <GO>
Revenue Growth (YoY)	—	3.60%	—	TIE	/revenue-growth <GO>
Dividend Yield & FCF Payout Safety	0.00%	0.00%	0.00	TIE	/dividend-safety <GO>
Altman Z-Score & Debt/Equity	—	2.33	—	TIE	/balance-sheet <GO>
Piotroski F-Score Quality	—	8/9	—	TIE	/piotroski-score <GO>
Options Implied Move & Put/Call Skew	—	—	—	TIE	/options-implied-move <GO>
RSI-14 & 200D SMA Momentum	42.1	83.2	-41.09	PCRX	/rsi-technicals <GO>
10Y Yield & FRED Macro Beta	—	—	—	TIE	/macro-sensitivity <GO>
Forward P/E Multiple ACTIVE	—	—	—	TIE	/forward-pe <GO>
Enterprise Scale & Market Cap	$1.39B	$1.45B	-$61.8M	PCRX	/market-cap <GO>

5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY

FISCAL YEAR	AAPG REV	PCRX REV	AAPG GROSS %	PCRX GROSS %	AAPG FCF	PCRX FCF
FY 2025	—	$726.4M	—	79.4%	—	$136.7M
FY 2024	—	$701.0M	—	75.7%	—	$178.8M
FY 2023	—	$675.0M	—	—	—	$154.6M

FRED MACRO REGIME CORRELATION COMPARISON PEARSON r

AAPG // BETA —

PCRX // BETA —